The forecast for cardiac glycosides sales in Germany from 2024 to 2028 shows a stable trend with values held constant at $0.3 US Dollars PPP Per Capita through 2027, before a decline to $0.2 in 2028. As 2023 values are not provided, measuring the exact percentage variations is difficult. Nonetheless, a downward trend appears in 2028, indicating a shift in demand or market dynamics.
Future trends to watch for include:
- The potential impact of new medical treatments or alternatives affecting cardiac glycosides demand.
- Regulatory changes in Germany that could influence market dynamics or pricing.
- Technological advancements or new research impacting the therapeutic use of cardiac glycosides.
